Welcome to Day 3 of LCGC?s coverage of Pittcon 2011. Today, we present the 2011 LCGC Lifetime Achievement Award as part of our live theater, in booth #3217, at 10:30 a.m.
Welcome to Day 3 of LCGC’s coverage of Pittcon 2011. Today, we present the 2011 LCGC Lifetime Achievement Award as part of our live theater, in booth #3217, at 10:30 am. That presentation and interview will be followed by a full day of programming from ChromAcademy.
The winner of the 2011 LCGC Lifetime Achievement Award is James W. Jorgenson of the University of North Carolina at Chapel Hill. A thought leader in separation science, Jorgenson is well known for his breakthroughs in both capillary electrophoresis and ultrahigh-pressure liquid chromatography. His pioneering work on developed CE as a viable and powerful tool for microscale chemical separations; capillary gel electrophoresis later enabled the sequencing of the human genome. His later work on the use of ultra-high pressures in liquid chromatography, first published in 1997, is widely regarded as critical to the success of what is now known as UHPLC.
Jorgenson also was one of the first to study multidimensional chromatography or multidimensional electrophoresis coupling CE with HPLC, and later interfaced mass spectrometry to CE–HPLC to make a truly 2D hyphenated system. He continues to pursue techniques to greatly increase peak capacity in analytical separations, such as LC-CE, as well as techniques with extreme resolving power, such as flow counterbalanced capillary electrophoresis (FCCE), to solve problems in complex mixture analysis.
Following the Lifetime Achievement Award interview, programming in the LCGC Theater will continue with sessions presented by our partner, ChromAcademy. These will include presentations on future GC technologies and metabolic profiling, and live troubleshooting sessions at 12:15 p.m. and 2:15 p.m.: Bring your questions and problems!
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.